Ivim Health review
By Aminoscope editorial desk · Aminoscope
Two-part price structure
Our verdict
Ivim lists sermorelin at $129 plus membership advertised at $75/month and billed at $74.99. NAD⁺ has one- and two-month product prices, but the existing-member inclusion needs confirmation against the separate-billing terms.
Main trade-offs
- Medication and membership generally billed separately
- Sermorelin supply interval is not specified on the product page
Disclosure: Aminoscope is reader-supported. We may earn a commission from partner links, at no extra cost to you. This never changes our assessment. How we make money.
Compounded medicines are not FDA-approved. A licensed clinician must assess whether treatment is appropriate; availability does not establish safety or benefit.
Good fit
People already paying for an Ivim membership, or who want unlimited provider access bundled and will do the two-part arithmetic before comparing.
Consider other options if
Anyone who needs a confirmed all-in medication price, state eligibility and lab protocol before enrolling.
Cost and care at a glance
- Category
- Peptide telehealth
- Published cost
- Sermorelin $129 plus membership billed $74.99/mo; confirm product supply interval, lab charges and program commitment
- Availability
- Not published
Our review in detail
Full assessment
Ivim separates the medication price from clinical membership. Sermorelin is listed at $129 plus membership advertised at $75 a month and billed at $74.99, making the two recurring components $203.99 if the product is supplied monthly. Confirm that supply interval before treating it as a monthly quote. NAD⁺ also has a prepaid two-month option, and the product page’s existing-member inclusion needs clarification. Prescription medication is non-refundable, and refills require active membership.
What it is
Ivim offers weight management, hormone care and energy-related treatments. Its current sermorelin product is a sublingual dissolvable, while NAD⁺ is a weekly injection. Both require a clinician’s prescribing decision. Membership provides care-team access, check-ins, treatment adjustments and coaching; medication is generally billed separately. The public pages checked do not establish a complete state-by-product eligibility list or identify the pharmacy for an individual order.
How care works
A clinician reviews your history and determines the treatment plan. Membership auto-renews and must run the length of the clinical program; canceling ends future prescriptions. Confirm the lab protocol, any additional testing charge and your state’s eligibility before enrolling. The membership page lists a $99 at-home lab kit for men’s hormone health, but that does not prove that sermorelin or NAD⁺ requires that kit or includes labs. Confirm that the exact formulation you want is available in your state.
Costs, billing and cancellation
Sermorelin is $129 plus the separately billed $74.99 monthly membership (advertised as $75). The product page does not specify the supplied quantity or interval, so $203.99 is the sum of those two charges, not a verified monthly medication invoice. NAD⁺ lists $129 for one month or $149 paid upfront for two months, plus membership. Two $74.99 membership charges plus the $149 product would total $298.98 over two months before any promotion or other charge. However, the NAD⁺ page also says it is included for existing members, while the membership page says medication is billed separately. Confirm eligibility, quantity and repeat-shipment terms in writing. Do not assume that either product includes a free first membership month. Medication is non-refundable; canceled or unpaid membership stops shipments, and inactive time does not extend the medication program. Ask for the full program cancellation schedule, including any early-cancellation fee, before paying.
Medication and evidence
Compounded sermorelin and NAD⁺ are not FDA-approved. A licensed clinician must determine whether prescribing is appropriate. Sermorelin is described as a sublingual dissolvable and NAD⁺ as a weekly injection; route and formulation affect bioavailability, so findings from other formulations cannot establish equivalent effects. These sources do not establish clinical benefit for Ivim’s injected NAD⁺ formulation; oral NR/NMN biomarker trials cannot establish injection outcomes. Growth-hormone signaling is not itself proof of improved sleep, recovery or body composition from this sermorelin product. Ask about formulation-specific evidence, monitoring, adverse effects and approved alternatives. Confirm the dispensing pharmacy for your individual prescription. Brand-name GLP-1 products and compounded GLP-1 products should not be assumed equivalent. Individual results vary.
Sources checked October 23, 2026
Pros and watch-outs
What we like
- Product prices and separate membership fee are public
- NAD⁺ two-month supply shows its upfront charge
- Sublingual sermorelin offers a needle-free route
- Membership includes care-team support and coaching
Watch-outs
- Medication and membership generally billed separately
- Sermorelin supply interval is not specified on the product page
- NAD⁺ inclusion and separate-billing statements need clarification
- Active membership required for refills; medication non-refundable
- State eligibility, individual pharmacy and lab charges need confirmation
Best for
People already paying for an Ivim membership, or who want unlimited provider access bundled and will do the two-part arithmetic before comparing.
Who should look elsewhere
Anyone who needs a confirmed all-in medication price, state eligibility and lab protocol before enrolling.
Research relevant to Ivim Health
Explore the evidence and its limits. Findings apply to the formulation, route and population studied; they do not establish the quality or effectiveness of a provider’s products.
- Sermorelin benefits: does it work? What the trials show
A real GHRH drug, read against the anti-aging pitch: an approved growth-hormone-releasing analog with a pediatric track record, and a longevity case built more on biomarkers than outcomes.
- NAD+ injections: benefits, side effects, cost and what the evidence says
Subcutaneous NAD+ is sold as a cheaper, at-home alternative to the IV drip, through “near me” clinics or telehealth shipped to your door. It is compounded, not FDA-approved for wellness uses. Small IV studies and oral-precursor trials do not establish long-term benefits from home NAD+ injections.
How Ivim Health compares
A few alternatives worth a look, depending on what you’re optimizing for.
Luvo HealthAdults comparing bundled longevity care with a medication-specific quote
See Luvo Health →- System Labs
Sermorelin alongside NAD⁺, glutathione and B-12 from one service
See System Labs →
Telos RXComparing compounded injection and sublingual formats
See Telos RX →
More peptide telehealth reviews: Tyde WellnessValhalla VitalityVea HealthVigorMedsVita BellaVital Harmony Rx
Editorial research
How we assessed this. This review reflects Aminoscope’s own read of Ivim Health’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- What does Ivim cost including membership?
- Sermorelin is $129 plus membership billed at $74.99/month. That adds to $203.99, but confirm the product supply interval. NAD⁺ lists $129 for one month or $149 upfront for two months plus membership; existing-member inclusion needs clarification.
- Is NAD⁺ included for members?
- Its product page says yes, but the membership page says medication is billed separately. Ask which members qualify, how much is included and whether future shipments cost extra.
- Can I stop membership and keep receiving medication?
- No. The refund policy requires active paid membership for prescriptions and refills. Medication is non-refundable and inactive time does not extend your program.
- Are these FDA-approved treatments?
- Compounded sermorelin and NAD⁺ are not FDA-approved. Their marketed sleep, recovery or energy benefits should not be treated as established clinical outcomes; discuss the route, evidence and alternatives with your clinician.